Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

E
E Santagostino - Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients
  - The Detection of Lupus Anticoagulants in Hemophiliacs: The Need for Different Assay Systems
Eagle KA - Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events
Eastham D - Monocyte Recruitment and Increased Urokinase (uPA) Activity are Important for Thrombus Resolution
Easton L - Laboratory Assessment of von Willebrand Disorder (VWD): Reassessment of ABO-Blood Group, Gender and Age on Laboratory Parameters and the Potential Influence on a Diagnosis of Mild VWD and the Potential Association with Risk of Thrombosis
Ebbesen LS - The Whole Blood Coagulation Profile in Hyperhomocysteinemic Patients with Prior Thrombosis is Changed by Folic Acid Treatment as Evaluated by roTEG Thrombelastography
Eberl W - Does a F XIII – Deficiency Induce a Bleeding Tendency?
Eble JA - Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2
  - Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
Eby C - Use of the D-Dimer for Exclusion of VTE: Difficulties Revealed through the Proficiency Testing Program of the College of American Pathologists (CAP)
Echelard Y - Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts
Eckes B - Role of Integrin a2b1 in Thrombus Stabilization and Embolization
Eckly A - Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times
Eckman JR - Is the Novel Genetic Mutation, Prothrombin C20209T, an Independent Risk Factor for Stroke among African-Americans with Sickle Cell Anemia?
Eckstein R - Comparative Study of Fibrinolysis Test Systems with A Special Focus on Variable Sample Handling (Different Transport Modalities/Arterial and Venous Catheterization)
Edelmiro M - Structure-Function Analysis of the Prostaglandin H2 Synthase-1 Peroxidase Site
Edenberg H - Identifying Hemostatic Modifier Loci Ameliorating FVII-Insufficiency Using Phenotypic Differences between Strains
Édes I - Factor XIII Levels and Factor XIII a Subunit Val34Leu Polymorphism in Patients with Coronary Sclerosis and Myocardial Infarction
Edlund M - Role of the Thrombin Receptor (PAR-1) in the Regulation of Menstrual Bleeding
Edmunds Jr. LH - Activated Peripheral Mononuclear Cells Plus Soluble Plasma Tissue Factor (TF) Activate Factors VII and X in Cardiac Surgical Wounds
Edouard A - High Concentrations of Procoagulant Microparticles in Patients with Multiple Trauma
Edson B - Independent Qa Exercise to Validate Poc Coagulometer Reliability in Support of the Thinrs Trial and to Allay Perceptions of Possible Coagulometer Dysfunction
  - Independent QA Exercise to Validate INR Test Strip Performance and Evaluate Perceptions of Excess Test Strip Error Messages in Support of the THINRS Trial
Edwards VD - Detection of Platelet Dense Granule Deficiency in Pediatric Patients by Quantitative Electron Microscopy
Edwards S - Treatment of HIV Associated Thrombotic Thrombocytopenic Purpura-Importance of Prompt Diagnosis
Efron E - Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion
Egan B - Clotting Factor Prophylaxis in Boys with Haemophilia; Experience from a Single Australian Centre
Egberts JFM - Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment
  - Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis
Egorina E - Intersubject Variability in Intracellular and Surface Tissue Factor Distribution in LPS-Stimulated Monocytes
Eguchi Y - Protective Effect of Endothelial Injury Administrated by Antithrombin Concentrates and Neutrophil Elastase Inhibitor in Endotoxin-Treated Rat
Eguchi Y - Expression of Plasminogen Activator Inhibitor-1 and Bax in Porcine Liver Transplantation – Protective Effect of Tauroursodeoxycholic Acid to Apoptosis
Ehrlich YH - Phosphorylation of the Extracellular Domain of the F11R/JAM-1 and Its Role in Platelet Aggregation
Ehrlich YH - The Platelet/Endothelial Cell Adhesion Protein F11R (a.k.a. JAM-1) Is Present in Cerebral Blood Vessels, Meninges, the Choroid Plexus and on Neuronal Cells
Ehrlich HJ - A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
Ehrlich YH - Evidence of a Critical Role for F11R (a.k.a. JAM-1) in the Adhesion of Platelets to the Endothelium at the Onset of Inflammatory Thrombosis
Eichinger S - The Association Between Tissue Factor-Exposing Microparticles and the Activation of the Coagulation System in Cancer Patients
  - A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence
  - Risk Factors for the Postthrombotic Syndrome (PTS)
  - Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomised, Placebo-Controlled, Double Blind Trial
  - Prediction of the Risk of Recurrent Venous Thromboembolism by the Activated Partial Thromboplastin Time
  - Venous Thromboembolism in Inflammatory Bowel Disease: The Pathogenetic Role of Tissue Factor Exposing Microparticles
  - Diagnosis of Acute Idiopathic Thrombotic Thrombocytopenic Purpura by Rapid Detection of ADAMTS 13 IgG Antibodies
  - Tissue Factor Pathway Inhibitor and the Risk of Recurrent Venous Thromboembolism (VTE)
  - The Release of Tissue Factor Bearing Microparticles from a Human Urinary Bladder Tumor Cell Line Following Chemotherapy
Eid S - A Thirteen Year Retrospective Study of Inherited Bleeding Disorders in the Jordanian Population
Eidam A - Multicenter Evaluation of a New ELISA for the Determination of Prothrombin Fragment F 1+2
Eidinger GW - Initial Treatment of Patients with Acute Deep-Vein Thrombosis Using 8.000 IU Bid Low-Molecular-Weight Heparin Certoparin – A 24 Months Follow Up
Eifrig B - Platelet Microparticles (PMP) Are Increased in Patients with Localized Prostate Cancer and Correlate with Plasma Tissue Factor (TF) Antigen Levels
  - Self-assessment of Bleeding in Young Women – Results from a Multicenter Questionnaire
  - Experimental Metastasis and Tumor Cell-Induced Coagulopathy in Mice with Hemophilia A and the Effect of FVIII Replacement Therapy
Eigenthaler M - Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766
  - Inhibition of Platelet Activation in Rats with Severe Congestive Heart Failure by Treatment with an Endothelial NO-Synthase Enhancer
  - Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of Nitric Oxide Bioavailability
Eikelboom JW - Protein Z Gene Polymorphisms, Protein Z Concentration and Ischaemic Stroke
Eikelboom JW - Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial
Eikelboom JW - Low-Dose Aspirin for Secondary Prophylaxis of Vein Thrombosis – A Prospectively Planned Meta-Analysis
Eikenboom J - Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
Eikenboom HCJ - Association of Coagulation Factor VIII Haplotypes with Factor VIII Activity and the Risk of Venous and Arterial Thrombosis
Eikenboom J - Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
  - In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
  - Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
Eikenboom J - Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
Eikenboom J - Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Eikenboom HCJ - ABO Blood Group Genotypes and the Risk of Venous Thrombosis: Effect of Factor V Leiden
Eikenboom J - Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
  - Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
Eikenboom HCJ - Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis
Eikenboom JCJ - The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
Eikenboom J - Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
  - The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
  - Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
Eikenboom JCJ - Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
Eikenboom HCJ - The Effect of ABO Blood Group Genotypes on the Loading of von Willebrand Factor with A and B Antigens
Eikenboom J - Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
Eikenboom HCJ - Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis
Eikenboom J - A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
Eikvar L - Occult Bleeding During Long-term Treatment with Aspirin, Warfarin, or Both after Myocardial Infarction. A WARIS-II Subgroup Analysis
Eilertsen AL - Dose-Dependent And Differential Effects of Two Doses of Continuous Combined Hormone Replacement Therapy (HRT), Tibolone And Raloxifene on Markers of Coagulation Activation
Eilertsen KE - Interleukin-8 (IL-8) Generation in Whole Blood Is Related to Markers of Atherosclerosis
  - The Eskimo Diet: More Than Omega-3 Fatty Acids
Einarson T - Results from the Canadian Hemophilia Dose Escalation Prophylaxis Trial: An Update
Eisert R - Rotation Thromboelastometry in Patients Receiving Platelet Transfusion after Chemotherapy
  - Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia
Eisert RM - Therapeutic Monitoring Using Rotation Thromboelastometry in Patients with Coagulation Factor VIII Inhibitors
Eissner G - Defibrotide and Oligotide, Two DNA-Based Drugs, Protect Human Microvascular Endothelial Cells against Chemotherapy-Induced Damage and Activation
Ejiri S - Expression of Plasminogen Activator Inhibitor-1 and Bax in Porcine Liver Transplantation – Protective Effect of Tauroursodeoxycholic Acid to Apoptosis
Ekert H - Clotting Factor Prophylaxis in Boys with Haemophilia; Experience from a Single Australian Centre
Ekholm C - The Prevalence of Low von Willebrand Factor Activity and von Willebrand Disease Among Young Women with Bleeding Symptoms
Ekström B - A Single Preoperative dose of Tranexamic Acid Reduces Blood Loss and Heterologous Blood Transfusion in Radical Retropubic Prostatectomy
El Amara W - Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study
El Ayachi S - Polymorphism A36G of the Tumor Necrosis Factor Receptor 1 Gene Is Associated with HDL Cholesterol, TNFR1 and PAI-1 Levels in Obese Women
El Kheir D - Value of D-dimer, for the Exclusion of Deep Venous Thrombosis, in Different Pre-test Clinical Probability Categories
  - What Is the Real Contribution of Standardized Pre-test Clinical Probability Scores and D-dimer Assays to the Diagnostic Management of Deep Vein Thrombosis? Systematic Review of Clinical Outcome Studies
El Kheir D - Search for Novel Genetic Risk Factors in Venous Thromboembolism: Design of a Family Study
El Nemer W - Increased Adhesion of Erythrocytes from Patients with Polycythemia Vera Is Mediated by Lu/B-CAM
El Rouby S - A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System
  - Re-evaluation of Point-of-Care (POC) Monitors for Routine Oral Anticoagulation Clinic Use
  - Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI)
  - Evaluation of the Anticoagulant Effect of Enoxaparin by Using Clot Based Point of Care Tests
  - Effective Anticoagulation Self-Management in a Diverse Population of Oral Anticoagulation Patients Using the Protime System
El Sherbiny M - Soluble VEGF/sFlt-1 Ratio is Independent Predictor of AML Patient Outcome
Elalamy I - Risk of Venous Thromboembolism (VTE) Related to first Pregnancy in At-Deficient Women. One-Center Study of 43 Pregnant Women without Prophylaxis
  - The Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – Inhibits Thrombin Generation in vitro after Tissue Factor Pathway Activation
  - Influence of Fondaparinux on INR Expression in Patients Receiving Oral Vitamin K Antagonists
  - Atypical Mutations of the Prothrombin Gene Located at 20209, 20218 and 20219 Position: A Report of 10 Patients with Venous Thromboembolism History
  - Pregnancy-associated Venous Thrombosis (VTE) in Women with Hereditary Heterozygous Factor V Leiden or Factor II 20210A Gene Mutation or Both
  - Pregnancy-Associated Venous Thrombosis (VTE) in Women with Hereditary Heterozygous Factor V Leiden or Factor II 20210A Gene Mutation or Both
  - Retrospective Study of 41 Patients Homozygous for the Prothrombin G20210A Mutation
El-Ali M - How Strong Is the Presence of Both Prothrombin and MTHFR Mutation as a Causative Factor of Arterial Thrombosis in Healthy Young Individuals?
Elawady M - Divergent Patterns of Vascular Endothelial Growth Factor (VEGF) in Patients with Acute Leukemia
Elbaz O - Divergent Patterns of Vascular Endothelial Growth Factor (VEGF) in Patients with Acute Leukemia
  - Elevated Serum Nerve Growth Factor (NGF) Levels in Patients with Acute Leukemia and Lymphoma Especially with CNS Involvement
Elchaninov P - The 4g/5g Polymorphism of the Pai-1 Gene is Associated with Cerebrovascular Disease Development in Childhood and Juvenile Period
Elford H - Therapeutic Inhibition of Endothelial Tissue Factor Expression by Nitric Oxide and Other Agents in Sickle Transgenic Mice
Elfvinge P - Experience of Surgery with Continuous Infusion at Karolinska University Hospital in Patients With Hemophilia A and B, von Willebrand'S Disease and FVII-Deficiency
Elgue G - Tissue Factor Is Associated with a Negative Outcome of Clinical Islet Transplantation
Elias DJ - Venous Thrombosis in Males Is Associated with Dyslipoproteinemia Involving High Density Lipoprotein (HDL) Deficiency and Excess Low Density Lipoprotein (LDL)
  - Adiponectin Correlation with Plasma Lipoprotein Subclasses Determined by NMR and with the Risk of Venous Thrombosis
  - Genotype Associations with Dyslipoproteinemia in Male Venous Thrombosis Patients
Eliasson Å - The Risk of Proximal DVT and Pulmonary Embolism (PE) in Patients with Objectively Verified Arterial Thrombosis. A Population-Based Autopsy Study
Elice F - High Incidence and Transitory Nature of Acquired Resistance to Activated Protein C (aAPCR) in Patients with Multiple Myeloma
El-Idrissi A - The Platelet/Endothelial Cell Adhesion Protein F11R (a.k.a. JAM-1) Is Present in Cerebral Blood Vessels, Meninges, the Choroid Plexus and on Neuronal Cells
Elleman-Olesen M - A Comparison of the PK/PD of Tinzaparin in Pregnant Women and in Non-Pregnant Healthy Volunteers
Eller, Th, Schmitz FJ - Evaluation of a latex-based D-Dimer-Assay on Clinical Chemistry Analyser Olympus AU 640TM
Ellery P - Heparin Has Variable Effects on the Release of Glycosylphosphatidylinositol-Lipid Anchored TFPI from Human Umbilical Vein Endothelial Cells
Ellingsen C - The Association Between Diabetes and Venous Thromboembolism in African Americans and Caucasians and the Relationship with Peroxisome Proliferator-Activated Receptor Polymophisms
Elliott MA - Sensitivity of Dilute Russell's Viper Venom Time (DRVVT) to Coagulation Factor Deficiency: Effect on Testing for Lupus Anticoagulant
Elliott JI - Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome
Elliott MA - Congenital Platelet ADP Receptor (P2Y12) Deficiency: A Case Report
  - Evaluation of Glass versus Plastic Blood Collection Tubes Used in Coagulation Testing
Ellis SA - The b-Fibrinogen -1420G/A Promoter Polymorphism Influences Transcription through Differential Binding of FOXA/HNF3 and May Explain the Association of the -1420A-Containing Haplotype with Elevated Plasma Fibrinogen
Ellis A - Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis
  - Heparin Monitoring During Haemodialysis in Children
Ellwanger C - Selenium Causes Decreased Rolling and Adhesion of Monocytes under Venous Flow Conditions Via Shedding of L-Selectin (CD62L)
Elnoor IB - Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman
Elokdah H - Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis
Elvevoll EO - Interleukin-8 (IL-8) Generation in Whole Blood Is Related to Markers of Atherosclerosis
  - The Eskimo Diet: More Than Omega-3 Fatty Acids
Emanuel V - Inherited Thrombophilias in the Patients with Prosthetic Heart Valves
Emmerich J - Long-Haul Flights Do Not Activate Haemostasis in Young Healthy Men
  - Symptomatic Venous Thromboembolism and Mortality after Hip Fracture Surgery: The ESCORTE Study
EmmerichLévesque JH - Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens
Emsley J - Fine Mapping of the Prothrombin Binding Site in the Apple 1 Domain of Factor XI
Emsley J - Structural Studies of the Factor XI Dimeric Zymogen
Enayat MS - 41 Novel Factor VIII Mutations Identified in Haemophilia A Families from the UK Midlands Region
Enayat S - Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) – A UK National Study
Enayat MS - Pseudo von Willebrand Disease: 2B or not 2B? Cryoprecipitate Induced Platelet Aggregation Solves Hamlet's Dilemma
Enayat MS - Mutation Analysis of the Factor VIII Gene in 224 Iranian Families with Haemophilia A
Enayat MS - Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease
Enders G - In vivo Relevance of Platelets and the Fibrinogen Receptor GPIIb-IIIa for Experimental Melanoma Metastasis
Endoh I - Serum Amyloid A (SAA) Induces Monocyte Tissue Factor
Engelhardt W - Performance Evaluation of APC Resistance/FV Leiden Assay Applications on Routine Coagulation Analyzers
Engelhardt W - Multicenter Evaluation of a New ELISA for the Determination of Prothrombin Fragment F 1+2
Engelhardt W - Multicenter Evaluation of BCS® XP – A Further Development of the Widespread BCS® Coagulation Analyzer
Engelhardt W - Analytical Evaluation of a Fully Automated Chromogenic Assay for the Determination of Endogenous Thrombin Potential (ETP)
  - Direct INR Determination by Use of Linear or Orthogonal Regression
Engelmann B - Extracellular Nucleic Acids Serve as Novel Cofactors for Blood Coagulation Via Contact Pathway Activation
Engelmann L - Individual Efficacy Measurement of FVIII Replacement Therapy in Cell-based Monitoring Tests
  - Influence of Factor IIa- and Factor Xa-Inhibitors on Thrombin Generation in Platelet-Rich Plasma
  - Influence of Platelet Transfusion on Thrombin Generation in Patients with Bone Marrow Transplantation
  - Measuring Thrombin Generation as a General Parameter in Relation to Single Coagulation Tests
Engelsen J - Accuracy and Precision of International Normalized Ratios (INRs) for Two Point of Care Test Systems: Comparison with Laboratory INR Monitoring
Engl W - Immunate S/D – Results of a Phase III, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of Immunate Solvent Detergent in Previously Treated Patients with Severe or Moderately Severe Hemophilia A
Engová D - Satisfaction and Safety of Two Domiciliary Anticoagulation Services for Mobility-impaired Patients: Preliminary Trial Findings
Enjolras N - Selected Human/Porcine Point Substitutions Generated A Human FVIIIa with an Improved Stability
  - Mutations in the Protein C Binding Site of Factor VIII Lead to the Resistance of Activated Protein C Cleavage
Ennamany R - Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
Enomoto TM - Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model
Enouf J - A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis
Ensslen S - Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG
Eppihimer MJ - A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation
Epple G - Drugs with Anti-Prion Activity in Cell Culture Have Variable Effects on the Stimulation of Plasmin Generation by the Prion Protein NH2-terminal Fragment PrP23-110
Epstein SE - Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study
Er O - Thrombosis in Cancer Patients
Erahbor T - The Use of Cow-Brain Tissue as an Alternative Source of Tissue Thromboplastin for Prothrombin Time Tests
Eram SM - Carrier Testing of Hemophilia B by SSCP and Sequencing in One Iranian Family
Erber WN - Factor V Leiden and Aprotinin in Cardiopulmonary Bypass
Erger RA - Decreased Protein C Activation and Accelerated Thrombosis in Human Thrombomodulin Knockin Mice
Eriksen K - FVIIa Decreases Surgery-Induced IL-6 Response in Burn Patients Undergoing Excision and Skin Grafting
Eriksson BI - The Benefit-to-Risk Ratio of Fondaparinux Thromboprophylaxis in Patients Undergoing Major Orthopedic Surgery Is Independent of Age
Eriksson BI - Prevention of Venous Thromboembolism with an Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – in Elective Hip Replacement: A Dose-Ranging Study
Eriksson B - ASA and NSAIDs with Melagatran/Ximelagatran or Enoxaparin Do NOT Increase Bleeding in Patients Undergoing Joint Replacement Surgery. The METHRO III Study
Eriksson H - Does the PE Risk in Abdominal Cancer Reflect Location, Spread or Tumour Type? Observations from a Population-Based Autopsy Study
  - Prothrombotic Risk Assessment of Patients Receiving Ximelagatran for Secondary Prevention of Venous Thromboembolism
  - Prevalence and Risk of Pulmonary Embolism in Patients with Intracardiac Thrombosis. A Population-Based Study
Eriksson-Berg M - Effects of Oral Hormone Replacement Therapy (HRT) on Platelet Function, Inflammatory Markers and Matrix Metalloproteinases in Postmenopausal Women with Established Coronary Artery Disease
Ernest CS - Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects
  - Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation
Ertl G - Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of Nitric Oxide Bioavailability
  - Inhibition of Platelet Activation in Rats with Severe Congestive Heart Failure by Treatment with an Endothelial NO-Synthase Enhancer
  - Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766
Erwich JJHM - Fetal Loss in Hereditary Antithrombin, Protein C and Protein S Deficiencies
  - Reduction of Fetal Loss Rate by Anticoagulant Treatment during Pregnancy in Women with Hereditary Deficiency of Antithrombin, Protein C or Protein S Type I. A Prospective Study
Erwig LP - Altered Clearance of Apoptotic Endothelial Cells in the Presence of Antiphospholipid Antibodies Provides a Dual Mechanism for Thrombosis in Antiphospholipid Syndrome
Esbensen K - Reduced Fibrin Compaction and Increased Fibrin Formation Rate in Patients with End-Stage Renal Disease
Eschrich R - TECHNOTHROMBIN® TGA a Novel Thrombin Generation Assay Suitable for the New Routine Coagulation Analyzer Ceveron® Alpha
Escuriola C - Epitope Mapping During FVIII Inhibitor Eimination With Rituximab Reveals Conformational Epitopes on FVIII and Identifies Small Molecules Blocking Inhibitor and Targeting B Cells
  - Screening of Phage Displayed Random Peptide Libraries Reveals Conformational Epitopes of Inhibitors in a Haemophilia B Patient
Escuriola-Ettinghausen C - Individual Efficacy Measurement of FVIII Replacement Therapy in Cell-based Monitoring Tests
Eser B - Thrombosis in Cancer Patients
Eshghi P - High Sensitivity of Monochloroacetic Acid 1% Clot Lysis Test for Diagnosis of Severe FXIII Deficiency
Eskiocak M - The Prevalence of Von Willebrand's Disease in Trakya Region of Turkey
Esmon C - Protective Effect of Human Plasma-Derived Protein C in Septic Neonatal Mice
Esmon CT - Cardiovascular Risk Factors Contributing to Endogenous Thrombin Potential (ETP) in Type 2 Diabetes
Esmon CT - Measurements of Soluble Thrombomodulin Activity and Antigen: Factors Contributing to Variance and Potential for Identification of Protein Variants
España F - Decreased Plasma Levels of Activated Protein C in Young Survivors of Myocardial Infarction: Relationship with the Extent of Coronary Artery Disease
  - The C1418T Polymorphism in the Thrombomodulin Gene is Associated with Increased Levels of Circulating Activated Protein C and with Reduced Risk of Venous Thromboembolism
  - Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
  - Protein CValencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys)
Espinola R - High Molecular Weight Kininogen (HK) Fragments Stimulate the Secretion of Interleukin 1b (IL-1b) through CD11b/CD18 (Mac-1) in Human Blood Mononuclear Cells
Esposito E - Assessment of Protein S on Hepatopaths at the Last Stage
Esposito BA - Atorvastatin Delays Thrombus Formation and Inhibits Leukocyte-Firm Adhesion to Thrombi Following Laser-Induced Arterial Injury in the Mouse
Essayagh S - Microparticles from Smooth Muscle Cells Induce Endothelial Dysfunction, a Phenomenon Prevented by Glycoprotein IIb/IIIa Antagonists
Estellés A - Protein CValencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys)
  - Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
  - The C1418T Polymorphism in the Thrombomodulin Gene is Associated with Increased Levels of Circulating Activated Protein C and with Reduced Risk of Venous Thromboembolism
  - Decreased Plasma Levels of Activated Protein C in Young Survivors of Myocardial Infarction: Relationship with the Extent of Coronary Artery Disease
Etienne E - Supperiority of Intermittent Pneumatic Compression of the legs over Elastic Stockings to Prevent Venous Thrombosis in Patients with Acute Intra-Cerebral Hemorrhage: A Randomized Trial
Eto T - Inhibition of 5-Hydroxytriptamine2A (5-HT2A) Receptor Prevents Occlusive Thrombus Formation on Neointima of Rabbit Femoral Artery
Ettema HB - The Incidence of Venographically Detected Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
  - Incidence of Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
Eugène S - The Stable Prostacyclin Analog Iloprost Induces The Production of the Angiogenic Factor Oncostatin M by Monocytes in a p38K-dependent Pathway
Evangelista M - N-3 Polyunsaturated Fatty Acids Selectively Affect Circulating Microparticle Subpopulations in Patients with Myocardial Infarction
Evangelisti L - Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells
  - Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study
  - Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC)
Evans G - Gait Alterations Exist in Children with Haemophilia after Relatively Few Haemarthroses and Despite Prophylaxis – A 3D Motion Analysis Study
Evans G - Whole Blood and Plasma ‘Thrombus Generation’ Derived from Thromboelastography as an Alternative to Endogenous Thrombin Potential
  - The Effect of Corn Trypsin Inhibitor on Whole Blood Thrombin and Thrombus Generation Parameters
Evans S - A Familial Platelet Function Disorder Associated with Abnormal Signaling Through the Glycoprotein VI Pathway
Evans G - Ultrasound Diagnosis of Acute Joint Pain May Lead to More Effective and Efficient Use of Haemophilia Therapy
Evans G - Evaluation of Fluorogenic Substrates for the Monitoring of Thrombin Generation
Evans S - Evaluation of DiaMed Heparin/PF4 Testing for HIT
Evers EJ - Intravenous Leiomyosarcoma Presenting As Iliac Vein Thrombosis
Evers LM - Inhibition of Microparticle Release from Endothelial Cells Induces Apoptosis
  - Cell-derived Microparticles Contain Caspase 3 in Vitro and in Vivo
Everse SJ - Molecular Models of the Prothrombinase Complex
Evgen M - Inhibition of Catalytic Activity of Plasmin by Recombinant Human Prion Protein
Evgueni S - Inhibition of Catalytic Activity of Plasmin by Recombinant Human Prion Protein
Ewenstein B - Clinical Efficacy and Safety Evaluation of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) During Surgical and Invasive Procedures
  - Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age
Ewing NP - Prophylaxis with Factor Eight Inhibitor Bypassing Activity, Vapor Heated (FEIBA VH) Decreases Bleeding Frequency and Maintains or Improves Joint Status
Ewing N - Anamnestic Responses in Hemophilia Patients with Inhibitors on Continuous Prophylaxis with Factor Eight Inhibitor Bypassing Activity, Vapor Heated (FEIBA VH)
Exner M - Complement Component C5a Predicts Future Cardiovascular Events in Patients with Advanced Atherosclerosis
Exner T - A Minor Variation of the APTT Mixing Test Can Be Used to Identify Defects in the Contact Mechanism
Exner T - Procoagulant Phospholipid Activity Associates Not Only with Free Microparticles, But with Platelets and/or Microparticles Complexed to Erythrocytes and Leukocytes
  - Diagnostic Dilemma of a Patient with Strong Lupus Anticoagulant and Intramuscular Haemorrhage, Requiring Treatment with Recombinant FVIIa
  - Methodological Issues Which May Influence the Detection, Quantitation and Functional Assessment of Platelet-Derived Microparticles
  - Prothrombotic Potential of Sclerosants: In Vitro Effects on Coagulation, Red cells and Platelets
  - High Concentrations of Procoagulant Microparticles in Patients with Multiple Trauma
Externest D - Pharmacovigilance Evaluation with ReFacto®– 6 years Post-Licensure Experience With ReFacto®– Recombinant Factor VIII – in Germany and Austria
Eyries M - Hydrogen Peroxide Activation of Platelet-Derived Growth Factor D-chain Transcription Is Mediated by the Winged Helix-Turn-Helix Protein Ets-1 and its Interplay with Sp1
Ezban M - Modified Whole Blood Clotting Time Assay Detects Recombinant Human FVIIa and rFVIIa Analog NN1731 in Canine Hemophilia a Blood in a Dose-Dependent Fashion
Ezekowitz M - Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran in a Dose Finding Trial in Atrial Fibrillation